Showing results (1-10 of 336) with videos related to
Sort By:
Pageof 34
Toxicologic Pathology|November 29, 2013
Gut microbiota, low-grade inflammation, and metabolic syndromeBenoit Chassaing, Andrew T GewirtzBioessays : News and Reviews in Molecular, Cellular and Developmental Biology|January 11, 2016
Has provoking microbiota aggression driven the obesity epidemic?Benoit Chassaing, Andrew T GewirtzPlos One|April 5, 2018
Mice harboring pathobiont-free microbiota do not develop intestinal inflammation that normally results from an innate immune deficiencyBenoit Chassaing, Andrew T GewirtzInflammatory Bowel Diseases|March 20, 2018
Not so Splendid for the Gut MicrobiotaBenoit Chassaing, Andrew T GewirtzAmerican Journal of Physiology. Endocrinology and Metabolism|February 28, 2018
Microbiota and metabolism: what's new in 2018?Alexis Bretin, Andrew T Gewirtz, Benoit ChassaingCellular and Molecular Gastroenterology and Hepatology|March 6, 2019
Chronic Inflammatory Diseases: Are We Ready for Microbiota-based Dietary Intervention?Emilie Viennois, Andrew T Gewirtz, Benoit ChassaingGut|January 16, 2023
Akkermansia muciniphila counteracts the deleterious effects of dietary emulsifiers on microbiota and host metabolismNoëmie Daniel, Andrew T Gewirtz, Benoit ChassaingHepatology (Baltimore, Md.)|May 25, 2013
Microbiota-liver axis in hepatic diseaseBenoit Chassaing, Lucie Etienne-Mesmin, Andrew T GewirtzGastroenterology|August 31, 2014
Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in miceBenoit Chassaing, Ruth E Ley, Andrew T GewirtzCurrent Opinion in Gastroenterology|October 12, 2017
How diet can impact gut microbiota to promote or endanger healthBenoit Chassaing, Matam Vijay-Kumar, Andrew T GewirtzPageof 34